drugset / Trial / NCT04454281

Topical Naloxone to Diagnose Ocular Pain

NCT04454281

Phase 1 Completed 1 enrolled Seema Capoor
RandomizedCrossoverTriple-blindDiagnostic

Summary

Chronic ocular neuropathic pain may be misdiagnosed as dry eye disease. Our study aims to identify a population with previous monocular trauma and dry eye symptoms and differentiate neuropathic from dry eye pain using topical corneal naloxone hydrochloride.

Timeline

Start
2020-10-01
Primary completion
2020-12-03
Completion
2020-12-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule 0.02 mg Topical
Subject Naloxone Small molecule 0.08 mg Topical